KB Home
KBH
D.R. Horton
DHI
Meritage Homes
MTH
4
Strategy
MSTR
5
Adobe
ADBE
US Stock MarketDetailed Quotes
RMTI Rockwell Medical
- 1.080
- -0.020-1.84%
Trading Apr 30 13:01 ET
36.90MMarket Cap-35.99P/E (TTM)
1.100High1.050Low45.63KVolume1.060Open1.100Pre Close48.57KTurnover0.17%Turnover RatioLossP/E (Static)34.17MShares5.15052wk High1.13P/B29.02MFloat Cap0.86452wk Low--Dividend TTM26.87MShs Float207.899Historical High--Div YieldTTM4.55%Amplitude0.840Historical Low1.064Avg Price1Lot Size
Rockwell Medical Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 21.38%101.49M | 11.64%24.67M | 19.12%28.32M | 42.88%25.83M | 15.29%22.68M | 14.84%83.61M | 14.39%22.09M | 27.18%23.77M | -3.22%18.08M | 21.98%19.67M |
| Operating revenue | 21.38%101.49M | 11.64%24.67M | 19.12%28.32M | 42.88%25.83M | 15.29%22.68M | 14.84%83.61M | 14.39%22.09M | 27.18%23.77M | -3.22%18.08M | 21.98%19.67M |
| Cost of revenue | 12.14%84.01M | 9.42%21.03M | 2.36%22.08M | 24.84%21.28M | 14.90%19.61M | 8.98%74.91M | 13.26%19.22M | 20.40%21.57M | 0.65%17.05M | 0.94%17.07M |
| Gross profit | 100.87%17.48M | 26.52%3.63M | 183.33%6.24M | 340.46%4.55M | 17.89%3.06M | 113.49%8.7M | 22.65%2.87M | 183.40%2.2M | -40.80%1.03M | 430.66%2.6M |
| Operating expense | 9.77%16.88M | 21.45%4.15M | 9.24%4.3M | 1.08%4.04M | 8.99%4.39M | -26.29%15.37M | -20.65%3.42M | -12.17%3.94M | -35.89%3.99M | -31.06%4.03M |
| Selling and administrative expenses | 18.15%16.86M | 27.70%4.15M | 24.91%4.3M | 5.49%4.04M | 16.60%4.37M | -19.57%14.27M | -21.71%3.25M | -14.22%3.45M | -27.84%3.83M | -12.29%3.75M |
| -Selling and marketing expense | 29.36%2.75M | 55.82%843K | 30.58%726K | 10.57%586K | 19.28%594K | 1.48%2.13M | 54.13%541K | -27.03%556K | 0.76%530K | 9.45%498K |
| -General and administrative expense | 16.19%14.11M | 22.08%3.31M | 23.81%3.58M | 4.67%3.45M | 16.18%3.78M | -22.39%12.14M | -28.72%2.71M | -11.22%2.89M | -30.99%3.3M | -14.88%3.25M |
| Research and development costs | -98.28%19K | -99.40%1K | --0 | --0 | -93.53%18K | -64.51%1.11M | 7.69%168K | 5.33%494K | -81.97%167K | -82.26%278K |
| Operating profit | 109.12%608K | 5.12%-519K | 211.46%1.94M | 117.40%515K | 7.22%-1.32M | 60.25%-6.67M | 72.18%-547K | 53.16%-1.74M | 33.98%-2.96M | 78.46%-1.43M |
| Net non-operating interest income expense | 44.40%-1.16M | 75.61%-260K | 23.38%-272K | 35.55%-223K | -26.01%-407K | -9.83%-2.09M | -169.19%-1.07M | 26.35%-355K | 28.66%-346K | 40.19%-323K |
| Non-operating interest income | -56.40%92K | -30.95%29K | -46.43%30K | -81.63%9K | -62.50%24K | 539.39%211K | --42K | --56K | --49K | --64K |
| Non-operating interest expense | -45.50%1.25M | -73.92%289K | -26.52%302K | -41.27%232K | 11.37%431K | 18.85%2.3M | 158.28%1.11M | -14.73%411K | -18.56%395K | -28.33%387K |
| Other net income (expense) | -76.95%74K | -77.23%23K | 51K | 7,925.00%321K | 101K | 220K | ||||
| Gain on sale of security | -76.95%74K | -77.23%23K | ---- | --51K | ---- | 7,925.00%321K | --101K | --220K | ---- | ---- |
| Income before tax | 94.31%-480K | 50.00%-756K | 188.89%1.66M | 110.38%343K | 1.09%-1.73M | 54.82%-8.44M | 35.99%-1.51M | 55.32%-1.87M | 33.46%-3.31M | 75.57%-1.75M |
| Income tax | ||||||||||
| Net income | 94.31%-480K | 50.00%-756K | 188.89%1.66M | 110.38%343K | 1.09%-1.73M | 54.82%-8.44M | 35.99%-1.51M | 55.32%-1.87M | 33.46%-3.31M | 75.57%-1.75M |
| Net income continuous Operations | 94.31%-480K | 50.00%-756K | 188.89%1.66M | 110.38%343K | 1.09%-1.73M | 54.82%-8.44M | 35.99%-1.51M | 55.32%-1.87M | 33.46%-3.31M | 75.57%-1.75M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 94.31%-480K | 50.00%-756K | 188.89%1.66M | 110.38%343K | 1.09%-1.73M | 54.82%-8.44M | 35.99%-1.51M | 55.32%-1.87M | 33.46%-3.31M | 75.57%-1.75M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 101.33%302K | 150K | ||||||||
| Net income attributable to common stockholders | 90.90%-782K | 36.34%-1.06M | 188.89%1.66M | 110.38%343K | 1.09%-1.73M | 54.02%-8.59M | 29.64%-1.66M | 55.32%-1.87M | 33.46%-3.31M | 75.57%-1.75M |
| Basic earnings per share | 91.89%-0.03 | 20.00%-0.04 | 171.43%0.05 | 105.56%0.01 | 40.00%-0.06 | 71.76%-0.37 | 75.00%-0.05 | 69.57%-0.07 | 58.14%-0.18 | 88.10%-0.1 |
| Diluted earnings per share | 91.89%-0.03 | 20.00%-0.04 | 157.14%0.04 | 105.56%0.01 | 40.00%-0.06 | 71.76%-0.37 | 75.00%-0.05 | 69.57%-0.07 | 58.14%-0.18 | 88.10%-0.1 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀